3DPrint.com May 15, 2024
Vanesa Listek

Building on its proven track record in groundbreaking projects like glaucoma stents and microneedles, Boston Micro Fabrication (BMF) launched a new subsidiary, BMF Biotechnology Inc. Headquartered in San Diego, California, the division uses the brand’s 3D printing technology to create and commercialize microfluidic chips that accurately mimic human body functions. These organ-on-a-chip platforms or BioChips will allow faster, more precise testing and research for pharmaceutical and cosmetic industries, opening up new possibilities for medical progress and better patient care.

What Are BioChips?

Equipped with an integrated network of tiny channels that function similarly to blood vessels in the human body, these chips allow the flow of fluids, mimicking how nutrients and wastes are exchanged in human tissues. This is key...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Technology
Bioprinting set to revolutionize primary health care by lowering costs and expediting services
The Bioprinting Frontier: Key Trends Driving Innovation
Study Explores Potential Of 3D Printed Regenerative Breast Implants
The Bioprinting World Map Reimagined: The Evolution from 2019 to 2024
Building new bones with help from 3D printing

Share This Article